(Q37818131)

23 August 2017

1 reference

title

The potential role of B cell-targeted therapies in multiple sclerosis (English)

1 reference

23 August 2017

0 references

Aaron Boster

1

1 reference

23 August 2017

Daniel P Ankeny

series ordinal

2

1 reference

23 August 2017

Michael K Racke

series ordinal

3

1 reference

23 August 2017

1 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

70

1 reference

23 August 2017

18

1 reference

23 August 2017

2343-2356

1 reference

https://scigraph.springernature.com/pub.10.2165/11585230-000000000-00000

23 August 2017

0 references

cites work

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

Determinants of Human B Cell Migration Across Brain Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

Mechanism of action of mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11585230-000000000-00000

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

21 January 2018

1 reference

12 December 2020

B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

1 reference

12 December 2020

B-cells in multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis--the plaque and its pathogenesis

1 reference

12 December 2020

Systemic humoral factors participating in the course of spinal cord injury

1 reference

12 December 2020

Can the immune system be harnessed to repair the CNS?

1 reference

12 December 2020

Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

1 reference

12 December 2020

NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCzeta

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

B cells and antibodies in CNS demyelinating disease

1 reference

12 December 2020

Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

1 reference

12 December 2020

Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells.

1 reference

12 December 2020

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Role of C5a in inflammatory responses

1 reference

12 December 2020

Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury

1 reference

12 December 2020

Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.

1 reference

12 December 2020

A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease

1 reference

12 December 2020

1 reference

12 December 2020

Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.

1 reference

12 December 2020

Intrathecal activation of the complement system and disability in multiple sclerosis.

1 reference

12 December 2020

Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis

1 reference

12 December 2020

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

12 December 2020

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein

1 reference

12 December 2020

Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

12 December 2020

A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases.

1 reference

12 December 2020

BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors

1 reference

12 December 2020

Immunogold localization and analysis of IgG during immune-mediated demyelination

1 reference

12 December 2020

Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?

1 reference

12 December 2020

B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice

1 reference

12 December 2020

T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis

1 reference

12 December 2020

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

12 December 2020

Think membranes and ion channels.

1 reference

12 December 2020

Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS

1 reference

12 December 2020

Immunomodulatory effects of interferon beta-1a in multiple sclerosis

1 reference

12 December 2020

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

1 reference

12 December 2020

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

1 reference

12 December 2020

Human and murine lymphocyte neurotrophin expression is confined to B cells

1 reference

12 December 2020

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice.

1 reference

12 December 2020

A study of oligoclonal band negative multiple sclerosis.

1 reference

12 December 2020

Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy

1 reference

12 December 2020

Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis

1 reference

12 December 2020

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

12 December 2020

A role for B cell-activating factor of the TNF family in chemically induced autoimmunity

1 reference

12 December 2020

Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response

1 reference

12 December 2020

Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries

1 reference

12 December 2020

Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein

1 reference

12 December 2020

B cells and autoantibodies: complex roles in CNS injury

1 reference

12 December 2020

Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients

1 reference

12 December 2020

Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

1 reference

12 December 2020

Effective suppression of cerebrospinal fluid B cells by rituximab and cyclophosphamide in progressive multiple sclerosis

1 reference

12 December 2020

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

12 December 2020

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.

1 reference

12 December 2020

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice

1 reference

12 December 2020

Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis

1 reference

12 December 2020

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

12 December 2020

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

1 reference

12 December 2020

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

1 reference

12 December 2020

Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury

1 reference

12 December 2020

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

1 reference

12 December 2020

Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis

1 reference

12 December 2020

Nerve growth factor is an autocrine survival factor for memory B lymphocytes.

1 reference

12 December 2020

Immunoglobulins promote remyelination in the central nervous system

1 reference

12 December 2020

Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

1 reference

12 December 2020

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

12 December 2020

Cerebrospinal fluid markers in multiple sclerosis: an overview

1 reference

12 December 2020

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

12 December 2020

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

12 December 2020

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

1 reference

12 December 2020

B cells regulate autoimmunity by provision of IL-10.

1 reference

12 December 2020

B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo

1 reference

12 December 2020

Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.

1 reference

12 December 2020

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination

1 reference

12 December 2020

Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

1 reference

12 December 2020

TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS

1 reference

12 December 2020

Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis

1 reference

12 December 2020

Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein

1 reference

12 December 2020

Insights into the immunopathogenesis of multiple sclerosis

1 reference

12 December 2020

Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.

1 reference

12 December 2020

Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients

1 reference

12 December 2020

10.2165/11585230-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference